We are live on ! Find out more
TMBR

Timber Pharmaceuticals, Inc.
TMBR

Delisted

TMBR was delisted on the 28th of November, 2023.

Back to rankings

14 hedge funds and large institutions have $10.2M invested in Timber Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

159% more capital invested

Capital invested by funds: $3.94M → $10.2M (+$6.27M)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

8% more funds holding

Funds holding: 13 → 14 (+1)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$4.37M
2
Franklin Resources
Franklin Resources
California
+$1.49M
3
EC
EcoR1 Capital
California
+$455K
4
SCM
Sio Capital Management
New York
+$389K
5
RI
RTW Investments
New York
+$194K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$114K
2
NC
Nexthera Capital
New York
-$32K
3
TCM
Tenor Capital Management
New York
-$7K
4
UBS Group
UBS Group
Switzerland
-$5.11K
5
VKH
Virtu KCG Holdings
New York
-$5.11K
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Vivo Capital
California
$4.79M +$4.37M +854 New
Franklin Resources
2
Franklin Resources
California
$3.55M +$1.49M +291 +85%
EC
3
EcoR1 Capital
California
$502K +$455K +89 New
RI
4
RTW Investments
New York
$476K +$194K +38 +81%
SCM
5
Sio Capital Management
New York
$428K +$389K +76 New
SM
6
Sabby Management
Florida
$265K +$15.3K +3 +7%
Vanguard Group
7
Vanguard Group
Pennsylvania
$100K +$40.9K +8 +80%
PAM
8
Panagora Asset Management
Massachusetts
$30K – – –
DCM
9
DAFNA Capital Management
California
$29K +$25.6K +5 New
LPL Financial
10
LPL Financial
California
$15K – – –
FWSM
11
First Wilshire Securities Management
California
$10K – – –
VKH
12
Virtu KCG Holdings
New York
$4K -$5.11K -1 -50%
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$4K – – –
TSS
14
Two Sigma Securities
New York
$4K +$5.11K +1 New
UBS Group
15
UBS Group
Switzerland
$3K -$5.11K -1 Closed
BFA
16
BlackRock Fund Advisors
California
$1K – – –
AFM
17
Anson Funds Management
Texas
– -$114K -14 Closed
NC
18
Nexthera Capital
New York
– -$32K -4 Closed
TCM
19
Tenor Capital Management
New York
– -$7K -1 Closed

TMBR Hedge Fund Activity: Q4 2016 in Review

14 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q4 2016, worth a combined $10.2M — up 159% from $3.94M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TMBR positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $4.37M. The largest seller was Anson Funds Management, exiting entirely with an estimated $114K sold.

  • 14 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q4 2016, up from 13 in Q3 2016.
  • Funds reported $10.2M of Timber Pharmaceuticals, Inc. stock for Q4 2016, up 159% quarter-over-quarter.
  • 5 funds opened new Timber Pharmaceuticals, Inc. positions in Q4 2016 and 4 closed out, a net change of +1 holder.
  • The largest Timber Pharmaceuticals, Inc. buyer in Q4 2016 was Vivo Capital, an estimated $4.37M added.
  • The largest Timber Pharmaceuticals, Inc. seller in Q4 2016 was Anson Funds Management, an estimated $114K sold.

Based on aggregated 13F filings for Q4 2016.